Literature DB >> 15292885

The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy.

Frank S Pidcock1.   

Abstract

Therapeutic injections of botulinum toxin have been used for the past decade to decrease muscle tone in children with cerebral palsy. Although this unique intervention has been shown to provide safe localized spasticity reduction, functional benefits have been more difficult to demonstrate. Appropriate selection of patients and clearly defined goals are key factors in the success of a treatment program. The therapeutic approach to treating children with cerebral palsy should include a variety of complementary interventions that address the effect of abnormal muscle tone on the abilities of these children as they grow and develop. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292885     DOI: 10.1016/j.jpeds.2004.05.020

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Anatomic localization of motor entry points and intramuscular nerve endings in the hamstring muscles.

Authors:  X C An; J H Lee; S Im; M S Lee; K Hwang; H W Kim; Seung-Ho Han
Journal:  Surg Radiol Anat       Date:  2010-01-10       Impact factor: 1.246

Review 2.  Pharmacologic interventions for reducing spasticity in cerebral palsy.

Authors:  Dilip R Patel; Olufemi Soyode
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

Review 3.  Botulinum toxin in children with cerebral palsy.

Authors:  Pratibha Singhi; Munni Ray
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

Review 4.  Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Authors:  Marissa Barlaan Lukban; Raymond L Rosales; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

5.  Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.

Authors:  Kristie Bjornson; Ross Hays; Cathy Graubert; Robert Price; Francine Won; John F McLaughlin; Morty Cohen
Journal:  Pediatrics       Date:  2007-07       Impact factor: 7.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.